SCHEMBL7557415

SCHEMBL7557415

O=C(Oc1ccccc1Br)N1CCN2CCC1CC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 3/20 0.66
HTR3A P46098 1/20 0.66
CHRNA3 P32297 4/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1948268 0.84 CHRNA7 (0.67) CHRNA7HTR3ACHRNA3
SCHEMBL5914704 0.83 CHRNA3 (0.66) CHRNA7HTR3ACHRNA3
SCHEMBL7553951 0.83 CHRNA7 (0.66) CHRNA7HTR3ACHRNA3
SCHEMBL5914723 0.83 CHRNA7 (0.66) CHRNA7HTR3ACHRNA3
SCHEMBL12615469 0.82 CHRNA7 (0.68) CHRNA7HTR3ACHRNA3
SCHEMBL4196882 0.81 CHRNA7 (0.75) CHRNA7HTR3ACHRNA3
SCHEMBL5914733 0.80 CHRNA7 (0.61) CHRNA7HTR3ACHRNA3
SCHEMBL7559030 0.80 CHRNA7 (1.00) CHRNA7HTR3ACHRNA3
SCHEMBL5914693 0.79 CHRNA7 (0.60) CHRNA7HTR3ACHRNA3
SCHEMBL5914669 0.78 CHRNA7 (0.62) CHRNA7HTR3ACHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177591-A1 Pharmaceutical compositions for the treatment of CNS and other discorders PFIZER INC. 2002-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177591-A1 Pharmaceutical compositions for the treatment of CNS and other discorders CHRNA7, CHRNA5, CHRNA10 CHRNA7 1/4885HTR3A 98/4885CHRNA3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.